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Edited by Sandro SonninoAbstract A role for cytosolic malonyl-CoA decarboxylase
(MCD) as a regulator of fatty acid oxidation has been postu-
lated. However, there is no direct evidence that MCD is present
in the cytosol. To address this issue, we performed cell fraction-
ation and electron microscopic colloidal gold studies of rat liver
to determine the location and activity of MCD. By both meth-
ods, substantial amounts of MCD protein and activity were
found in the cytosol, mitochondria and peroxisomes, the latter
with the highest speciﬁc activity. MCD species with diﬀerent
electrophoretic mobility were observed in the three fractions.
The data demonstrate that active MCD is present in the cytosol,
mitochondria and peroxisomes of rat liver, consistent with the
view that MCD participates in the regulation of cytosolic malo-
nyl-CoA levels and of hepatic fatty acid oxidation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cell fractionation1. Introduction
Malonyl-CoA, which is produced by acetyl-CoA carboxyl-
ase (ACC), is central to many cellular processes, including
fatty acid (FA) biosynthesis and oxidation. It is considered
an intracellular signal of nutrient abundance that regulates fuel
partitioning in various tissues [1–4]. In addition, malonyl-CoA
has been implicated in the control of insulin secretion [5], insu-
lin sensitivity [3] and by virtue of its eﬀects on speciﬁc hypo-
thalamus nuclei, food intake [6].
Cloning of the rat malonyl-CoA decarboxylase (MCD) re-
vealed that the enzyme contains both mitochondrial and perox-Abbreviations: ACC, acetyl-CoA carboxylase; CPT1, carnitine palmi-
toyltransferase 1; FA, fatty acid; MCD, malonyl-CoA decarboxylase
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initiation site after the mitochondrial presequence [7]. Recent
studies have focused on the possibility that MCD regulates
intracellular malonyl-CoA levels. Despite this, knowledge of
the regulation of malonyl-CoA level by MCD is incomplete
and the precise role of MCD in various intracellular compart-
ments is uncertain. Importantly, to date it has not been ﬁrmly
established that the enzyme is present in the cytosol, the loca-
tion of the pool of malonyl-CoA that controls FA oxidation
by allosterically inhibiting carnitine palmitoyltransferase 1
(CPT1) [8].
Recent work has provided evidence that an increase in or
the maintenance of MCD activity in conjunction with a de-
crease in ACC activity is in part responsible for the decrease
in malonyl-CoA levels and increased FA oxidation in the rat
heart both postnatally and during reperfusion following
ischaemia [9,10]. It has also been demonstrated that MCD
is activated in liver, skeletal muscle and adipose tissue of
the rat following a bout of exercise and that this is associated
with reduced levels of malonyl-CoA and enhanced fat oxida-
tion [11] although others have shown that in the heart MCD
does not regulate malonyl-CoA levels unless MCD is phar-
macologically inhibited [10,12]. Other indirect evidence sup-
porting a role of MCD in FA oxidation is derived from an
engineered cytosolic MCD. In our laboratory, MCD overex-
pression in the cytosol of pancreatic b-cell dramatically re-
duced malonyl-CoA levels and increased FA oxidation [13]
and similar ﬁndings have been made in liver overexpressing
an engineered cytosolic MCD [14]. Collectively, these results
suggest a role for cytosolic MCD as a regulator of FA oxida-
tion. Despite this, direct evidence that MCD is present in the
cytosol of any tissue in a normal physiologic situation and
that it is biologically active is still lacking. To address these
questions, we performed both cell fractionation and electron
microscopic colloidal gold studies in rat liver to determine the
location and the activity of MCD in three subcellular com-
partments (mitochondria, peroxisome, cytosol) thought to
play a role in FA oxidation. The results indicate that enzy-
matically active MCD is present in comparable amounts in
all three compartments with the speciﬁc activity greatest in
mitochondria and peroxisomes. They also suggest that the
molecular species of MCD found in these fractions are not
identical.blished by Elsevier B.V. All rights reserved.
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2.1. Subcellular fractionation
Male fed 175–200 g Sprague–Dawley rat (Charles Rivers, St-Con-
stant, QC, Canada) were anesthetized by an injection of 60 mg/kg of so-
dium pentobarbital and sacriﬁced by exsanguination in accordance
with the policies of the Centre Hoˆpitalier de lUniversite´ de Montre´al
animal ethics committee. Livers were removed, weighed and 4 g of liver
were cut into 0.5 cm pieces. The samples of liver were washed twice with
homogenization buﬀer containing ice-cold 0.25 mM sucrose, 1 mM
EDTA, 5 mM Mops (pH 7.2), 0.1% ethanol and protease inhibitors
and then homogenized in 10 ml of the same buﬀer using a Potter–Elveh-
jem homogenizer. The homogenate was ﬁltered through cotton–cheese
mesh to remove unbroken tissue and centrifuged at 10000 · g for
20 min at 4 C to prepare a light-mitochondrial fraction supernatant.
An aliquot (1 ml) of the supernatant was layered on top of a pre-formed
Optiprep gradient (10 ml; 20–40% (w/v) iodixanol) supported by a
cushion of 50% (w/v) Iodixanol (1 ml) as described by Veldhoven and
colleagues [15]. Gradients were centrifuged at 125000 · g for 1 h in
an SW41 rotor (Beckman Instrument, Mississauga, Ont., Canada)
and fractionated [15]. Twenty-ﬁve fractions of 0.55 ml were collected
following the gradient centrifugation. Proteins from the odd fractions
were precipitated using ethanol (75% ﬁnal), centrifuged (15000 · g
for 30 min at 4 C), dissolved in PBS and separated by SDS–PAGE
(see Section 2.3). Even fractions were used to determine MCD activity.
2.2. Antibody production
A speciﬁc antibody against rat MCD [7] was raised by immunizing
rabbits with a chemically derived peptide H-M-D-E-L-L-R-R-A-V-P-
P-T-P-D-Y (in single acid code) corresponding to the amino acid 39–
53 of the rat MCD (GenBank accession number: AJ007704) as de-
scribed by Harlow and Lane [16]. IgG fractions were made from rabbit
sera using Protein-A sepharose (Amershaw BioSciences, Baie dUrfe´,
QC, Canada) as described in the manufacturers protocol.
2.3. Immunodetection of MCD
Proteins from the odd fractions were precipitated as described above
and dissolved in 500 ll of PBS. The protein content of each fraction was
measured using the BCA reagent (Pierce, Rockford, IL). For each frac-
tion, 30 ll of precipitated protein were analyzed on a 10% SDS-contain-
ing polyacrylamide gel. Proteins were then transferred to nitrocellulose
ﬁlters and MCD was detected using an IgG fraction (see Section 2.2) at
2–3 lg/ml and a horseradish peroxidase-conjugated goat anti-rabbit
immunoglobulin antibody from Bio-Rad (Hercules, CA) at a dilution
of 1:20000. Detection of chemiluminescence was carried out using the
ECL reagent (Amershaw Biosciences) andMCD bands were quantiﬁed
by densitometric analysis. After this, the MCD bands were erased by
incubating the membranes in 62 mM Tris (pH 6.8), 2% SDS and
100 mM b-mercaptoethanol for 30 min at 60 C and the membranes
were reprobed with the following antibodies against organelle-speciﬁc
markers. A rabbit polyclonal antibody against the cytosolic protein
matricin (also known as TCP1c [17]) and; a rabbit anti-catalase poly-
clonal antibody (Chemicon International, Temecula, CA) at a dilution
1:2000 against the peroxisomal enzyme catalase. We identiﬁed mito-
chondrial fractions using a monoclonal anti-oxphos (2E3) antibody
against oxidative complex II of the electron transport chain (Molecular
Probes, Eugene, OR) and a horseradish peroxidase-conjugated goat
anti-mouse IgG antibody (Bio-Rad) at a dilution 1:20000, and using
a goat anti-acyl-CoA dehydrogenase (Abcam, Cambridge, MA) at
0.1 lg/ml and a horseradish peroxidase-conjugated goat anti-goat
IgG antibody (Santa-Cruz Biotechnology, Santa-Cruz, CA) at a dilu-
tion of 1:20000.
2.4. MCD assay
MCD activity was assayed by coupling the MCD reaction to the cit-
rate synthase and the glutamate-oxaloacetate transaminase reactions
in the presence of [14C]aspartate to form [14C]citrate [18]. [14C]citrate
was separated from unreacted [14C]aspartate using Dowex resin and
centrifugation [7,11].
2.5. Electron microscopy
Liver tissue from male Sprague–Dawley rats fed ad libitum was ﬁxed
by immersion with 1% glutaraldehyde in 0.1 M phosphate buﬀer (pH
7.4) for 2 h at 4 C. The tissue was then dehydrated in methanol andembedded in Lowicryl according to previously reported procedures
[19]. Ultrathin sections were mounted on Parlodion and carbon coated
grids and processed for immunocytochemistry. The protein A–gold
immunocytochemical technique [19] was applied to reveal MCD in
rat liver tissue. The MCD speciﬁc polyclonal antibody (see above)
was used at 1/20 dilution. Tissue sections were incubated for 15 min
with 1% ovalbumin in PBS and then transferred to the speciﬁc anti-
body. The incubation with the antibody was carried out for 24 h at
4 C. Upon rinsing with PBS, the sections were incubated with the pro-
tein A–gold complex (10 nm gold particles) for 30 min at room temper-
ature. Finally, after thorough washing with PBS, the sections were
counterstained with uranyl acetate and examined with a Philips 410
electron microscope. Tissues from three animals were included in the
study and four independent labeling protocols were carried out. In
addition to labeling with the IgG fraction containing the MCD speciﬁc
antibody, several control experiments were performed to assess the
speciﬁcity of the results. In these studies we used the rabbit serum sam-
pled prior to raising the antibody (pre-immune serum), adsorbed the
antibody with an excess of its speciﬁc antigen, or simply omitted the
antibody step in the labeling protocol. Quantitative evaluations of
the labelings were carried out as described previously [19]. Approxi-
mately 30 ﬁelds of diﬀerent hepatocytes were recorded at the original
magniﬁcation of 12000· and at a magniﬁcation of 36000·. Gold par-
ticles present among the rough endoplasmic reticulum and between cis-
ternae but not within cisternae or on the luminal side of endoplasmic
reticulum membrane were considered as located in the cytosol as de-
scribed previously for cytosolic proteins [20–23]. The areas of the mito-
chondrial, peroxisomal, nuclear and cytoplasmic compartments were
evaluated by planimetry and the number of gold particles in each com-
partment counted. The density of labeling, expressed as number of
gold particles per unit area of surface was calculated. Quantitative
evaluations were carried out on sections processed for the speciﬁc
labeling as well as for the diﬀerent controls. A Carl Zeiss Videoplan
unit was used for these evaluations.
2.6. Calculations and statistics
Data analysis and graphs were performed using PRISM 4.0a soft-
ware (GraphPad Software, San Diego, CA). Data were analyzed using
the unpaired two-tailed t-test. P < 0.05 was considered signiﬁcant.
Data are expressed as means ± standard error of the mean (S.E.).3. Results
3.1. Cell fractionation
Fig. 1A shows the separation of the cytosolic, mitochondrial
and peroxisomal fractions on an Optiprep gradient. The cyto-
sol, identiﬁed with an antibody against matricin (Mat blot)
sedimented mainly in fractions 21–25 with traces in fractions
15–19. The peroxisomes (Cat blot) sedimented mainly in frac-
tions 9–17 and the mitochondria (Oxphos and Acad blots) pre-
dominantly in fractions 15–21 with traces noted in fractions
11–13 and 23–25. MCD was found in all three compartments
(MCD blot). Interestingly, we found MCD species with diﬀer-
ent electrophoretic mobility in the three fractions (see a, b and
c of MCD blot). In the cytosol, a species (a) migrating at 52–
54 kDa was detected. This species was also found at low levels
in mitochondrial fractions 17, 19 and 21 and could have
resulted from a small contamination with cytosol. A
50–51 kDa species (b) was found in both mitochondrial and
peroxisomal fractions and a 48–49 kDa species (c) was found
mainly in the peroxisome fraction.
Fig. 1B shows the mean intensity of MCD bands from three
independent experiments that were quantiﬁed by densitometry.
The MCD protein was found in the peroxisomes (fractions 9–
17), the cytosol (fractions 21–25) and to a lesser extent in the
mitochondria (fractions 15–21), thus conﬁrming the ﬁndings
illustrated in Fig. 1A. Fig. 1C shows total and speciﬁc MCD
Fig. 1. Enzymatically active MCD is found in puriﬁed cytosolic,
mitochondrial and peroxisomal subcellular fractions. Rat livers were
homogenated and fractionated using an Optiprep gradient as described
in Section 2. A and B, proteins from each fraction were separated by
SDS–PAGE and transferred onto nitrocellulose for immunodetection
using a speciﬁc antibody against MCD. Following the immunodetec-
tion of MCD, the blots were erased and reprobed using organelle-
speciﬁc antibodies for matricin (Mat) a cytoplasmic (Cyt) chaperonin;
the complex 2 of the electron chain (Oxphos) that is located in the
inner mitochondrial membrane (Mtmb); catalase (Cat), a peroxisomal
enzyme (Per); and for acyl-CoA dehydrogenase (Acad), a mitochon-
drial matrix enzyme (Mtmx). Protein bands were revealed by chemi-
luminescence and were quantitated by densitometric analysis of the
autoradiograms (MCD Protein in B). In panel A, a, b and c indicate
the various MCD isoforms found in the diﬀerent cell compartments. C
total and speciﬁc MCD activities were quantiﬁed for each fraction.
Per, Mtm and Cyt indicate the position of the peroxisomal,
mitochondrial and cytosolic compartments, respectively. Panel A is a
representative experiment. Data in panels B and C are means ± S.E. of
three experiments.
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protein and activity were found in the cytosol and in the mito-
chondria and peroxisomes, the latter with the highest speciﬁcactivity. The cytosol contained the lowest speciﬁc activity but
total activity in this compartment was relatively high. A precise
quantitative assessment of total activity in the three compart-
ments could not be made using the fractionation approach
since only the even fractions were assessed for MCD activity.
3.2. Electron microscopic analyses
Fig. 2 shows that upon applying the protein A–gold immu-
nocytochemical technique on rat liver tissue sections with the
anti-MCD antibody, a labeling by gold particles was obtained
over certain cellular compartments of the hepatocyte. Mito-
chondria and peroxisomes display a distinct labeling. The label
was located in the matrices of both of these organelles. The
nucleotide bodies in the peroxisomes were devoid of labeling.
Gold particles were found in the cytosol throughout the cell.
They were counted as follows. The vast majority of gold par-
ticles that were found in proximity of the rough endoplasmic
reticulum or between cisternae, did not have the characteristic
labeling pattern of a protein associated with the rough endo-
plasmic reticulum and were therefore considered present in
the cytosol. The very few gold particles that were found within
the endoplasmic reticulum cisternae or located on the luminal
side of endoplasmic reticulum were not counted. This method-
ology to assess a cytoplasmic protein using immunogold is an
established procedure that has previously been used by our
group [20,21] as well as others [22,23]. In contrast, other cellu-
lar compartments such as the nuclei and lysosomes were essen-
tially devoid of labeling. Under control conditions, in
particular with the anti-MCD antibody absorbed with an
excess of its antigen (Fig. 2C) or with preimmune serum, cell
labeling was drastically reduced, conﬁrming the speciﬁcity of
the labelings obtained with the anti-MCD antibody.
Quantitative evaluation essentially conﬁrmed the subjective
observations. Table 1 reports the densities of labeling obtained
over diﬀerent cellular compartments in speciﬁc and control
conditions. The mitochondria appear to display the most
intensive labeling while the peroxisomes and cytosol showing
lower but highly signiﬁcant labeling. Values obtained for the
nuclei were in the range of those obtained under control con-
ditions (Table 1).4. Discussion
The results conclusively demonstrate that MCD is localized
and enzymatically active in three subcellular components: the
cytosol, mitochondria and the peroxisomes in rat hepatocytes.
They also demonstrate that MCD species with diﬀerent elec-
trophoretic mobilities are present in these fractions.
In previous studies [4,24,25] suggestive evidence for the pres-
ence of MCD in the cytosol was obtained. However, the results
were not entirely conclusive because signiﬁcant contamination
of the cytosol by other cell compartments was noted [4,24] or,
in studies with cultured cells, the enzyme was overexpressed
[25,26]. In an attempt to remedy these methodological prob-
lems, we developed a liver cell fractionation procedure with
very little inter-organelle/compartment contamination and
used electron microscopic colloidal gold methodology to
examine the location and activity of MCD in the three subcel-
lular compartments of liver, thought to play a role in FA oxi-
dation. The conclusions of the present study are based on four
ﬁndings: First, both cell fractionation and immunoelectron
Fig. 2. Subcellular localization of MCD in rat hepatocytes using the immunogold electron microscopy technique. A and B Protein A–gold
immunolabeling of MCD. The gold particles revealing MCD antigenic sites are located over the mitochondria (M) and the peroxisomes (P). Gold
particles are also seen in the cell cytosol (arrows) among the rough endoplasmic reticulum (RER) and other organelles. The glycogen deposits (G)
appear clear because the glycogen particles were extracted during tissue preparation. N, nuclei. In C, the control condition, the tissue section was
incubated with the anti-MCD antibody adsorbed with an excess of its antigen, followed by the protein A–gold complex. Very few gold particles are
present over mitochondria (M), peroxisomes (P) and the cell cytoplasm. Magniﬁcation: 35000·.
Table 1
Quantitative immunocytochemistry of MCD in rat hepatocytes
Anti MCD Preimmune serum Adsorption pAg
Peroxisomes 8.29 ± 2.14* 1.94 ± 0.45 0.61 ± 0.07 0.83 ± 0.48
Mitochondria 14.36 ± 1.90* 1.84 ± 0.27 0.30 ± 0.17 0.16 ± 0.03
Cytosol 5.93 ± 1.05* 1.29 ± 0.22 0.60 ± 0.15 0.22 ± 0.07
Nucleus 0.78 ± 0.27* 0.22 ± 0.10 0.20 ± 0.10 0.16 ± 0.03
The densities are expressed as gold particles/lm2. Anti MCD, preimmune serum, adsorption and pAg refer to labelling with the IgG fraction
containing the MCD-speciﬁc antibody, preimmune serum, IgG fraction adsorbed with an excess of MCD peptide used for immunization, and with
the antibody step omitted, respectively.
*Signiﬁcantly diﬀerent (P < 0.01) from the other values in the same row.
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existence of cytosolic MCD. Second, a possible contamination
of the cytosol fractions by MCD leaking out from mitochon-dria that might be damaged, did not appear suﬃcient to con-
found interpretation of the data. Thus, although trace
amounts of the mitochondrial markers (Oxphos and Acad)
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and were totally insuﬃcient to account for the intense MCD
bands observed in either the cytosol or peroxisomes. This is
particularly apparent for the mitochondrial matrix enzyme
acyl-CoA dehydrogenase (Acad) [27] that was found in minute
amounts in the cytosol fractions indicating that mitochondrial
leakage minimally contaminated the cytosol. Third, immuno-
blots revealed the presence of organelle-speciﬁc diﬀerent
molecular weight species of MCD. The highest Mw species
(52–54 kDa) was found almost exclusively in the cytosol with
trace amounts noted in the mitochondria, possibly due to con-
tamination by the cytosol. The intermediate species (50–
51 kDa) was found only in mitochondria and peroxisomes
and the lowest Mw species (48–49 kDa) was present exclusively
in the peroxisomes. Other laboratories [25,26] using adenovi-
rally expressed or transfected MCD, have reported the pres-
ence of diﬀerent MCD species; but to our knowledge, this is
the ﬁrst time that the existence of diﬀerent MCD species and
their organelle speciﬁcity has been observed in untransfected
tissue. Whether the diﬀerent molecular weight species reﬂect
transcriptionally or post-transcriptionally generated isoforms
or proteolytic modiﬁcation of the enzyme remains to be estab-
lished. Fourth, cell fractionation studies showed that MCD
was enzymatically active in the three subcellular compart-
ments.
Our results are not consistent with a previous cell fraction-
ation study [24], which concluded that MCD is not present
in the mitochondria. The reason for this discrepancy is unclear
although the other study did not assess cytosolic markers and
did not discount the possibility of mitochondrial leakage and
cross-contamination between the two compartments.
The colloidal gold electron microscopy results in Table 1
show that the highest density of MCD is found in mitochon-
dria, whereas Fig. 1B (cell fractionation/immunoblot) indicates
that MCD intensity is greater in the peroxisomes and cytosol.
The reason for this discrepancy is uncertain but a likely possi-
bility is the following. For the sake of performing good cell
fractionation (with well-separated subcompartments), we pre-
pared a post-light mitochondrial instead of a post-nuclear
supernatant. By doing so very large and/or aggregated mito-
chondria occurring during the homogenization process were
discarded. Thus, the total MCD protein content in mitochon-
dria is probably underestimated in Fig. 1B compared to Table
1.
Cytosolic malonyl-CoA is both a substrate for fatty acid
synthase, the ﬁrst committed enzyme responsible for the de-
novo synthesis of FA, and an allosteric inhibitor of CPT1,
the rate-limiting enzyme for the transfer of long chain fatty
acyl-CoA into mitochondria where they are oxidized. Prior
studies have demonstrated the regulation of malonyl-CoA by
ACC in many tissues. The presence of active MCD in the cyto-
sol strongly suggests that cytosolic MCD also participates in
regulating this pool of malonyl CoA. The relative importance
of the two enzymes in vivo in diﬀerent situations and in other
tissues (e.g., muscle) remains to be determined.
It has been hypothesized that the role of mitochondrial
MCD is to protect speciﬁc matrix enzymes, such as methylmal-
onyl-CoA mutase and pyruvate carboxylase, from inhibition
by mitochondrially derived malonyl-CoA [28]. Scholte [28]
suggested that propionyl-CoA carboxylase could produce
some malonyl-CoA from acetyl-CoA in mitochondria and
that it would be used as a false substrate. Our ﬁndings arecompatible with this putative role as electron microscopy re-
vealed MCD in the matrix of mitochondria where all of the en-
zymes mentioned above are localized.
The presence of active MCD in the peroxisomes could be ex-
plained by the presence of peroxisomal-speciﬁc CPT1 [8]. Per-
oxisomal CPT1, like the enzyme in mitochondria is sensitive to
malonyl-CoA [29]. Thus, it is possible that peroxisomal MCD
regulates peroxisomal CPT1 by modulating malonyl-CoA lev-
els in the vicinity of this organelle. We do not favor this possi-
bility since the electron microscopy (Fig. 2) revealed that MCD
was almost exclusively located in the matrix of the peroxisome,
with very little if any associated with the membrane. Another
possibility is that MCD protects peroxisomal enzymes from
malonyl-CoA inhibition, as was proposed for mitochondria.
Clearly, further experiments are needed to delineate the role
of peroxisomal MCD.
The presence of MCD in three subcellular compartments is
intriguing and additional roles of the enzyme can be envisaged.
Long chain FA elongation requires malonyl-CoA as a sub-
strate and this elongation process has been documented to oc-
cur in mammalian mitochondria [30–32] and microsomes
[31,33–35]. To our knowledge, it is not known whether it oc-
curs in peroxisomes. It may be hypothesized that organelle
malonyl-CoA derives from cytosolic malonyl-CoA via the pro-
duction of cytosolic malonate. If so, a malonate/acetyl-CoA
cycling (malonate input/acetyl-CoA output) across both the
mitochondria and peroxisome membrane might play a role
in the control of long chain FA elongation in these organelles.
Finally, it may be hypothesized that an additional role of both
cytosolic and organelle MCD is to protect cells from malonate
by catalyzing the formation of acetyl-CoA from malonyl-CoA.
Hypothetically, this would diminish malonate formation due
to the deacylation of malonyl-CoA. In this context, malonate
which is present at relatively high levels in some tissues like
brain [36], is a potent inhibitor of several enzymes including
succinate dehydrogenase.
In summary, the data provide conclusive evidence that enzy-
matically active MCD is present in three subcellular compart-
ments of liver tissue: cytosol, mitochondria and peroxisomes.
The cytosolic localization of the enzyme suggests that MCD
by its eﬀect on the concentration of malonyl-CoA can function
as a regulator of fat oxidation and lipid partitioning.
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